Page 7 - Solara Active Pharma Sciences News Today

Markets open on positive note: Sensex up 172 points, Nifty above 14,650 Kunal Patil/ PTI The stock markets opened on a positive note on Thursday. The benchmark indices were in the green. Sensex rose over 172 points in early trade on Thursday, tracking gains in index majors HDFC twins, ITC and Bajaj Finance amid largely positive cues from Asian peers. The 30-share BSE index was trading 174.54 points or 0.36 percent higher at 48,852.09 in initial deals. NSE Nifty advanced 69.05 points or 0.47 per...

As per the bulk deal data on the NSE, BNP Paribas Arbitrage sold 5,14,463 equity shares or 1.43% stake of Solara Active Pharma Science at Rs 1,463 per share on Monday, 19 April 2021. On the same day, the Scottish Oriental Smaller Companies Trust Plc bought 1,99,259 equity shares or 0.55% stake of Solara Active Pharma Science at Rs 1,462.25 per share via bulk deal on NSE. As of 31 March 2021, BNP Paribas Arbitrage held 3.50% stake in Solara Active Pharma Science. Shares of Solara Active Pharma f...

Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12 News18 1 hour ago © Provided by News18 Infosys, JSW Steel, TCS: Top Stocks for Investors on April 12 The stock market on Friday, April 9, gave a negative ending after starting the day on a flat note led by banking stocks. Following the same trend, the indices on Monday, April 12, are expected to open lower as the SGX Nifty was trading at 51.00 points or 0.34 percent down at 14,821.00 at 7:05 am. On April 9, the BSE Sensex fell b...

Here are the top stocks that are likely to be in focus today: Earnings Today: Tata Consultancy Services, HDIL, California Software, Cupid Trades & Finance and Lloyds Metals and Energy will announce their quarterly earnings on April 12. Analysts expect TCS to post 9 per cent YoY growth in March quarter revenue aided by certain large deals such as Postbank and Prudential Financial, ramp-up in multiple $50-100 million deals won in the preceding quarter, and strong demand in areas of cloud and cus...

The board of directors of Solara Active Pharma Sciences on 9 April 2021 approved the amalgamation of Aurore Life Sciences, Empyrean Lifesciences and Hydra Active Pharma Sciences with the company.The combination creates a pure play API company of scale with strong presence in regulated markets, emerging markets, a broad product portfolio, robust operations infrastructure, excellent R&D capabilities and clear synergies to further accelerate growth for the combined entity. The merger is EPS accre...

Here are a few stocks which may buzz the most in todays trade.

At meeting held on 03 February 2021The Board of Solara Active Pharma Sciences at its meeting held on 03 February 2021 has approved the acquisition of additional share capital in Sequent Penems (SPPL), subsidiary company of Solara. Currently Solara holds 89.23% of SPPL and it is proposed to acquire remaining 10.77% to make it as a wholly owned subsidiary. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated fee...

Solara Active Pharma Sciences Limited to acquire balance 10.77% stake in Sequent Penems Pvt Ltd Posted On: 2021-02-03 05:53:43 (Time Zone: Arizona, USA) The Board of Solara Active Pharma Sciences Limited at its meeting held today (February 3, 2021) has approved to acquire additional share capital in Sequent Penems Private Limited (SPPL), subsidiary company of Solara. Currently Solara holds 89.23% of SPPL and it is proposed to acquire remaining 10.77% to make it as a wholly owned subsidiary...